ABEONA THERAPEUTICS INC.
ABEONA THERAPEUTICS INC. (ABEO): 11 pipeline candidates · ~25 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
25.3 months
D/E 0.37 · 0% dilution
Lead: BLA Filed
11 candidates
N/A
0 buys · 25 sells (180d)
A transparent, data-derived signal for ABEONA THERAPEUTICS INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$324.6M
Cash
$61.4M
Quarterly Burn
$19.8M
Runway
25.3 mo
Revenue
$8.7M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (11 candidates)
| Drug | Phase |
|---|---|
| aav204 | Preclinical |
| ABO-503 | Preclinical |
| ABO-504 | Preclinical |
| ABO-505 | Preclinical |
| abo-701 | — |
| CLN1 program (out-licensed to Taysha) | — |
| prademagene zamikeracel (pz-cel) | BLA Filed |
| pz-cel | BLA Filed |
| Rett syndrome program (out-licensed to Taysha) | — |
| UX111 (ABO-102) | BLA Filed |
Showing 10 of 11 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
104
Total value held
$135.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 4,329,702 | $19.4M |
| blackrock, inc. | 3,195,530 | $14.3M |
| suvretta capital management, llc | 2,676,000 | $12.0M |
| kennedy capital management llc | 1,263,511 | $5.7M |
| geode capital management, llc | 1,209,797 | $5.4M |
| goldman sachs group inc | 1,130,619 | $5.1M |
| susquehanna international group, llp | 1,108,670 | $5.0M |
| state street corp | 957,328 | $4.3M |
| nan fung trinity (hk) ltd | 956,770 | $4.3M |
| stonepine capital management, llc | 846,587 | $3.8M |
Showing top 10 of 104 institutional holders of ABEONA THERAPEUTICS INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in ABEONA THERAPEUTICS INC.'s pipeline?
ABEONA THERAPEUTICS INC. (ABEO) has 11 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ABEONA THERAPEUTICS INC.'s lead drug candidate?
ABEONA THERAPEUTICS INC.'s most advanced tracked candidate is aav204 (Preclinical) for Ophthalmology indications.
What is ABEONA THERAPEUTICS INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ABEONA THERAPEUTICS INC. has approximately 25.3 months of cash runway.
What is ABEONA THERAPEUTICS INC.'s market capitalization?
ABEONA THERAPEUTICS INC.'s market capitalization is approximately $324.6M.
Who is the CEO of ABEONA THERAPEUTICS INC.?
Dr. Vishwas Seshadri M.B.A., Ph.D. is the chief executive officer of ABEONA THERAPEUTICS INC. (ABEO).
Get the full picture on ABEONA THERAPEUTICS INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.